(Reuters) - Merck & Co's immunotherapy Keytruda plus chemotherapy significantly improved overall survival versus chemotherapy alone in newly-diagnosed patients with advanced non-small cell lung cancer in a highly-anticipated study that appears to cement the company's lead in the most lucrative oncology market.


60


Reuters

Latest News

CTV News: New Brunswick Tories win most seats

Reuters: Factbox: Who would oversee the Mueller investigation after Rosenstein?

Reuters: Instant View: Deputy Attorney General Rosenstein heads to White House amid reports he will resign

Reuters: After chaotic day, Rosenstein stays in job but will meet with Trump

Reuters: Instagram says CEO Systrom, CTO Krieger resign

NewYorkTimes: Iran’s Terms to Reopen Nuclear Talks? Trump Has to Back Down

FOX: White House: We are so proud of Brett Kavanaugh

FOX: Meadows: Rosenstein needs to be transparent with Americans

FOX: Meadows: Rosenstein needs to be transparent with Americans

ABC: Athletics clinch playoff berth with Rays' loss to Yankees

ABC: Instagram co-founders resign from social media company

Daily Mail: Video: Lady Gaga teases a new song in trailer for 'A Star is Born'

Daily Mail: Mandy Moore stuns in a black leather dress and towering booties on The Tonight Show

Daily Mail: Kluber earns 20th win as Indians blank White Sox

Daily Mail: Yankees´ Hicks leaves game with tight hamstring

Daily Mail: Bringing Up Bates' star Carlin Bates announces engagement to 'man of my dreams' Evan Stewart

Daily Mail: Taillon outpitches Hamels, Pirates beat Cubs 5-1.

Daily Mail: Hilary Duff covers baby bump in grey sweater sweater while enjoying shopping spree in Studio City

Daily Mail: Instagram co-founders resigning: report

Daily Mail: Matildas squad named for Euro friendlies

Daily Mail: Storm halves freshened up for NRL decider

Daily Mail: 'Ka pai': New Zealand's Maori language back from brink

CTV News: Charges laid after Brampton collision kills woman, two kids

17 Related Articles, between 2018-03-22 and 2018-04-16